To develop new pleuromutilin derivatives as veterinary antibiotic medicines, we designed and synthesized a series of new thioether pleuromutilin derivatives possessing acylthiazolyl moiety based on previously designed derivatives. The antibacterial properties of the prepared pleuromutilin derivatives were assessed in vitro by the broth dilution method against five kinds of bacteria and the mycoplasma Mycoplasma gallisepticum (MG). All of the tested compounds displayed moderate to good antibacterial activity to methicillin-sensitive Staphylococcus aureus (MSSA), methicillin-sensitive Staphylococcus epidermidis (MSSE), methicillin-resistant S. aureus (MRSA), Streptococcus agalactiae (S. aga) and MG. However, the activity to Pyogeniccoccus (Pyogens) was generally poor. Compounds 13i and l showed potent antibacterial activity against MSSE and MRSA which are better than that of valnemulin. The structural modification for pleuromutilin affected the antibacterial activity. Amino substituents in the benzene ring can effectively improve activity. Compared with the analogue 13a that possesses unsubstitution benzoyl group, the nitro, methoxy, hydroxy and dichloro substituent contributed little to antibacterial activity. Increasing a methylene between benzene moiety and carbonyl group decreased the bioactivity of derivative. The analogues that obtained by the reaction of amino acids and intermediate 9 showed moderate activity.
为了开发新型
截短侧耳素衍
生物作为兽用抗生素药物,我们在先前设计的衍
生物基础上,设计并合成了一系列含有酰基
噻唑基团的新的
硫醚型
截短侧耳素衍
生物。通过肉汤稀释法,针对五种细菌和支原体鸡败血支原体(MG)对其抗菌活性进行了体外评估。所有测试化合物对
甲氧西林敏感的
金黄色葡萄球菌(MS
SA)、
甲氧西林敏感的表皮葡萄球菌(MS
SE)、
甲氧西林耐药的
金黄色葡萄球菌(MRSA)、无乳链球菌(S. aga)和MG显示出中等到良好的抗菌活性。然而,对化脓性葡萄球菌(Pyogens)的活性普遍较差。化合物13i和l对MS
SE和MRSA表现出强效的抗菌活性,优于
沃尼妙林。
截短侧耳素的结构修饰会影响抗菌活性。苯环上的
氨基取代基能有效提高活性。与具有未取代苯甲酰基的类似物13a相比,硝基、甲氧基、羟基和二
氯取代基对抗菌活性贡献不大。在苯环部分和羰基之间增加一个亚甲基会降低衍
生物的
生物活性。通过
氨基酸与中间体9反应得到的类似物显示出中等的活性。